Thomas DesRosier Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas DesRosier.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas DesRosier. Thomas DesRosier is Sr VP General Counsel in GENZYME CORP ($GENZ) and EVP, General Counsel in ARIAD PHARMACEUTICALS INC ($ARIA) and Chief Legal Officer and EVP in Seres Therapeutics, Inc. ($MCRB) and See Remarks in Seres Therapeutics, Inc. ($MCRB).
Latest Insider Trading Transactions of Thomas DesRosier
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, GENZ, MCRB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2021 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 26.34 | 100,000 | 2,634,000 | 100,000 | |
| Jan 31 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 3.30 | 350,000 | 1,155,000 | 350,000 | |
| Jan 28 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 28 2020 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Buy | M | 0.00 | 25,000 | 0 | 41,054 | 16.1 K to 41.1 K (+155.72 %) |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | M | 0.00 | 15,000 | 0 | 25,000 | |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 6.01 | 84,800 | 509,648 | 84,800 | |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Sell | S | 5.75 | 5,471 | 31,478 | 16,054 | 21.5 K to 16.1 K (-25.42 %) |
| Jan 29 2019 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Buy | M | 0.00 | 15,000 | 0 | 21,525 | 6.5 K to 21.5 K (+229.89 %) |
| Jan 30 2018 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Option Exercise | A | 10.42 | 100,000 | 1,042,000 | 100,000 | |
| Jan 30 2018 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Option Exercise | A | 10.42 | 80,000 | 833,600 | 80,000 | |
| Jan 30 2018 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Option Exercise | M | 0.00 | 10,000 | 0 | 40,000 | |
| Jan 30 2018 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Sell | S | 11.02 | 3,475 | 38,295 | 6,525 | 10 K to 6.5 K (-34.75 %) |
| Jan 30 2018 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 27 2017 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 27 2017 | MCRB | Seres Therapeutics ... | DesRosier Thomas | Chief Legal Officer ... | Option Exercise | A | 9.89 | 60,000 | 593,400 | 60,000 | |
| Jun 02 2016 | MCRB | Seres Therapeutics ... | DesRosier Thomas | See Remarks | Option Exercise | A | 30.90 | 100,000 | 3,090,000 | 100,000 | |
| Mar 30 2016 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Option Exercise | M | 0.00 | 55,000 | 0 | 55,000 | |
| Mar 30 2016 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Payment of Exercise | F | 5.03 | 18,370 | 92,401 | 36,630 | 55 K to 36.6 K (-33.40 %) |
| Mar 30 2016 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Buy | M | 0.00 | 55,000 | 0 | 55,000 | 0 to 55 K |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Option Exercise | A | 0.00 | 30,800 | 0 | 30,800 | |
| Mar 09 2016 | ARIA | ARIAD PHARMACEUTIC ... | DesRosier Thomas | EVP, General Counse ... | Option Exercise | A | 6.51 | 102,500 | 667,275 | 102,500 | |
| Aug 08 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Option Exercise | M | 32.52 | 10,725 | 348,777 | 0 | |
| Aug 08 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Sell | S | 78.99 | 10,725 | 847,168 | 716 | 11.4 K to 716 (-93.74 %) |
| Aug 08 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Buy | M | 0.00 | 10,725 | 0 | 11,441 | 716 to 11.4 K (+1,497.91 %) |
| May 27 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Option Exercise | A | 0.00 | 5,833 | 0 | 5,833 | |
| May 27 2008 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP General Couns ... | Option Exercise | A | 68.48 | 17,500 | 1,198,400 | 17,500 |
Page: 1